Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

D Bhojwani; R Sposto; NN Shah; V Rodriguez; C Yuan; M Stetler-Stevenson; MM O'Brien; JL McNeer; A Quereshi; A Cabannes; P Schlegel; C Rossig; L Dalla-Pozza; K August; S Alexander; JP Bourquin; C.M. Zwaan; EA Raetz; ML Loh; SR Rheingold

doi:10.1038/s41375-018-0265-z

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

D Bhojwani, R Sposto, NN Shah, V Rodriguez, C Yuan, M Stetler-Stevenson, MM O'Brien, JL McNeer, A Quereshi, A Cabannes, P Schlegel, C Rossig, L Dalla-Pozza, K August, S Alexander, JP Bourquin, C.M. Zwaan, EA Raetz, ML Loh, SR Rheingold

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

117 Citations (Scopus)

3 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	884-892
Number of pages	9
Journal	Leukemia
Volume	33
Issue number	4
DOIs	https://doi.org/10.1038/s41375-018-0265-z
Publication status	Published - 2019

Access to Document

10.1038/s41375-018-0265-z

Repub_116103_O-A.pdfFinal published version, 801 KB

http://hdl.handle.net/1765/116103

Cite this

Bhojwani, D., Sposto, R., Shah, NN., Rodriguez, V., Yuan, C., Stetler-Stevenson, M., O'Brien, MM., McNeer, JL., Quereshi, A., Cabannes, A., Schlegel, P., Rossig, C., Dalla-Pozza, L., August, K., Alexander, S., Bourquin, JP., Zwaan, C. M., Raetz, EA., Loh, ML., & Rheingold, SR. (2019). Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia, 33(4), 884-892. https://doi.org/10.1038/s41375-018-0265-z

@article{73b789a163994dbdbe309f577d4006d9,

title = "Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia",

author = "D Bhojwani and R Sposto and NN Shah and V Rodriguez and C Yuan and M Stetler-Stevenson and MM O'Brien and JL McNeer and A Quereshi and A Cabannes and P Schlegel and C Rossig and L Dalla-Pozza and K August and S Alexander and JP Bourquin and C.M. Zwaan and EA Raetz and ML Loh and SR Rheingold",

year = "2019",

doi = "10.1038/s41375-018-0265-z",

language = "Undefined/Unknown",

volume = "33",

pages = "884--892",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

Bhojwani, D, Sposto, R, Shah, NN, Rodriguez, V, Yuan, C, Stetler-Stevenson, M, O'Brien, MM, McNeer, JL, Quereshi, A, Cabannes, A, Schlegel, P, Rossig, C, Dalla-Pozza, L, August, K, Alexander, S, Bourquin, JP, Zwaan, CM, Raetz, EA, Loh, ML & Rheingold, SR 2019, 'Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia', Leukemia, vol. 33, no. 4, pp. 884-892. https://doi.org/10.1038/s41375-018-0265-z

TY - JOUR

T1 - Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

AU - Bhojwani, D

AU - Sposto, R

AU - Shah, NN

AU - Rodriguez, V

AU - Yuan, C

AU - Stetler-Stevenson, M

AU - O'Brien, MM

AU - McNeer, JL

AU - Quereshi, A

AU - Cabannes, A

AU - Schlegel, P

AU - Rossig, C

AU - Dalla-Pozza, L

AU - August, K

AU - Alexander, S

AU - Bourquin, JP

AU - Zwaan, C.M.

AU - Raetz, EA

AU - Loh, ML

AU - Rheingold, SR

PY - 2019

Y1 - 2019

U2 - 10.1038/s41375-018-0265-z

DO - 10.1038/s41375-018-0265-z

M3 - Article

VL - 33

SP - 884

EP - 892

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -